However, increased levels of FGFR4 expression have been detected in various cancers, such as breast cancer, hepatocellular carcinoma, renal cell carcinoma, lung cancer, and pancreatic cancer (Liu et al., 2020). Here, FGFR4 is linked to hepatocellular carcinoma.